Rejection

This section of the tutorial covers the main findings used to make the diagnosis of acute cellular rejection. It also has a brief word on antibody mediated rejection, which will be covered in greater detail in a forthcoming tutorial. It will consolidate the key concepts of the low power and high power sections.

Lymphocytic infiltrate

 

A lymphocytic infiltrate is the key histologic finding that indicates the process being observed is acute cellular rejection. At low power, this is seen as an increased area of cellularity. At high power lymphocytes must be evaluted for their injury to myocytes. Activated lymphocytes, which are associated with injury can have enlarged nuclei and increased cytoplasm compared to quiescent lymphocytes.

Low cellularity High cellularity Thrombus and fibrosis
 
 

Myocyte injury

 

Myocyte injury is the key feature to discriminate between low and high grades of rejection. Higher grades of rejection are 2R and 3R. Myocyte injury is best appreciated at high power where a variety of features can be noted. These include hypereosinophilia, nuclear pyknosis, myocytolysis, coagulative necrosis, vacuolization, perinuclear halo, and lymphocyte encroachment onto the myocyte. Sometimes myocyte injury is appreciated as an area with heavy lymphocytic inflammation where there has been myocyte dropout (empty spaces where myocytes should be) or "bits of myocytes" from the destructive process.

Low cellularity High cellularity Thrombus and fibrosis
 
 

Antibody Mediated Rejection

 
Antibody mediated rejection (AMR, AKA humoral rejection) is distinct from acute cellular rejection except in severe cases where the histologic findings may overlap. Histopathologic changes of AMR, seen on light microscopy, are endothelial cell swelling, macrophages filling small vessel lumens and edema. Staining for the complement split product C4d is generally used to identify the presence of AMR by immunohistochemistry or immunofluorescence.

  • Forward to non-rejection findings.
  • Backward to high power findings.
  •  

    Please take our short survey regarding the acute cellular rejection tutorial to let us know what you think of the tutorial and how it can be improved.

     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     

    The information on the Society for Cardiovascular Pathology's Web Site is provided with the understanding that the Society is not rendering medical advice, or recommendations. You should not rely on any information in the text files, messages, bulletin boards or articles on these pages to replace consultations with qualified health care professionals to meet your individual medical needs.